Christopher P Leamon Selected Research

Christopher P Leamon Research Topics

Disease

54	Neoplasms (Cancer) 01/2020 - 06/2002
7	Inflammation (Inflammations) 10/2021 - 12/2008
6	Ovarian Neoplasms (Ovarian Cancer) 07/2015 - 11/2012
3	Weight Loss (Weight Reduction) 01/2019 - 05/2007
3	Polycystic Kidney Diseases (Polycystic Kidney Disease) 01/2019 - 10/2012
3	Carcinoma (Carcinomatosis) 12/2018 - 03/2005
2	Cytokine Release Syndrome 10/2021 - 01/2019
2	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 09/2009
2	Neutropenia 12/2018 - 01/2013
2	Autosomal Dominant Polycystic Kidney (ADPKD) 01/2018 - 10/2012
2	Cysts 01/2018 - 10/2012
2	Lung Neoplasms (Lung Cancer) 01/2016 - 10/2014
2	Experimental Arthritis 07/2015 - 04/2011
2	Rheumatoid Arthritis 07/2015 - 04/2011
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2014 - 11/2012
2	Lymphoma (Lymphomas) 02/2014 - 05/2007
2	Ovarian Epithelial Carcinoma 12/2013 - 11/2012
2	Neoplasm Metastasis (Metastasis) 03/2013 - 01/2013
2	Constipation 02/2011 - 12/2009
2	Hypersensitivity (Allergy) 09/2009 - 09/2007
1	Glomerulonephritis 01/2021
1	Osteosarcoma (Osteogenic Sarcoma) 01/2019
1	Non-alcoholic Fatty Liver Disease 01/2019
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2019
1	Hematologic Neoplasms (Hematological Malignancy) 01/2019
1	Hypoxia (Hypoxemia) 10/2018
1	Fibrosis (Cirrhosis) 01/2018
1	Encephalomyelitis (Myeloencephalitis) 01/2014
1	Uveitis 01/2014
1	Pituitary Neoplasms (Pituitary Adenoma) 12/2013
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2013

Drug/Important Bio-Agent (IBA)

53	Folic Acid (Vitamin M)FDA LinkGeneric 01/2021 - 06/2002
20	Pharmaceutical PreparationsIBA 01/2020 - 04/2004
13	EC145IBA 12/2018 - 05/2007
8	Biological ProductsIBA 03/2019 - 07/2005
8	LigandsIBA 01/2019 - 04/2004
7	AlkaloidsIBA 12/2018 - 12/2009
6	HydrazinesIBA 04/2016 - 12/2009
5	tubulysin BIBA 01/2019 - 12/2008
5	HaptensIBA 09/2009 - 04/2004
4	Chimeric Antigen ReceptorsIBA 10/2021 - 01/2019
4	AminopterinIBA 01/2021 - 02/2011
4	AntigensIBA 01/2019 - 04/2004
4	Fluorescein (Funduscein)FDA LinkGeneric 01/2019 - 09/2007
4	Folic Acid AntagonistsIBA 10/2014 - 01/2008
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2008
3	Fluorescein-5-isothiocyanate (FITC)IBA 01/2019 - 12/2006
3	EC0305IBA 06/2017 - 12/2008
3	PlatinumIBA 10/2014 - 09/2013
3	AntibodiesIBA 02/2014 - 04/2004
3	Pemetrexed (MTA)FDA Link 11/2013 - 04/2010
2	Folate Receptor 2IBA 10/2021 - 01/2019
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 06/2002
2	isothiocyanic acidIBA 01/2019 - 06/2008
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 10/2014
2	EC0531IBA 12/2018 - 06/2017
2	Paclitaxel (Taxol)FDA LinkGeneric 12/2018 - 08/2006
2	Sirolimus (Rapamycin)FDA Link 01/2018 - 10/2012
2	HydrazonesIBA 04/2016 - 08/2006
2	EC 0746IBA 01/2014 - 04/2011
2	VitaminsIBA 06/2008 - 04/2004
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 08/2006 - 07/2005
1	InterleukinsIBA 10/2021
1	Interleukin-6 (Interleukin 6)IBA 10/2021
1	antiglomerular basement membrane antibodyIBA 01/2021
1	Folic Acid TransportersIBA 03/2019
1	CarbonIBA 03/2019
1	Docetaxel (Taxotere)FDA Link 01/2019
1	Cisplatin (Platino)FDA LinkGeneric 12/2018
1	Messenger RNA (mRNA)IBA 10/2018
1	Acetazolamide (Diamox)FDA LinkGeneric 10/2018
1	Fluorescent Dyes (Fluorescent Probes)IBA 10/2018
1	6-aminosaccharinIBA 10/2018
1	Carbonic Anhydrase IXIBA 10/2018
1	Coloring Agents (Dyes)IBA 10/2018
1	Mannitol (Osmitrol)FDA LinkGeneric 04/2016
1	AcetoneIBA 04/2016
1	Alanine (L-Alanine)FDA Link 04/2016
1	Antineoplastic Agents (Antineoplastics)IBA 04/2016
1	BuffersIBA 04/2016
1	Acetic Acid (Vinegar)FDA LinkGeneric 04/2016
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2016
1	EC0565IBA 07/2015
1	ArrestinIBA 01/2014
1	Retinaldehyde (Retinal)IBA 01/2014
1	Myelin Basic ProteinIBA 01/2014
1	liposomal doxorubicin (Doxil)FDA Link 12/2013
1	1-dodecylpyridoxal (PLD)IBA 12/2013
1	177Lu-EC0800IBA 11/2013
1	Radiation-Sensitizing AgentsIBA 11/2013
1	Radioisotopes (Radionuclides)IBA 11/2013
1	ThymidineIBA 03/2013
1	EC0905IBA 01/2013
1	MTOR InhibitorsIBA 10/2012
1	TOR Serine-Threonine KinasesIBA 10/2012

Therapy/Procedure

28	Therapeutics 10/2021 - 04/2004
6	Drug Therapy (Chemotherapy) 01/2019 - 08/2006
5	Immunotherapy 09/2009 - 04/2004
1	Palliative Care (Palliative Therapy) 11/2013
1	Intravenous Injections 11/2012